Lim, S.Y.; Kim, L.; Kim, H.; Park, J.-A.; Yun, J.; Lim, K.S.
Synergistic Chemo-Immunotherapy: Recombinant Fusion Protein-Based Surface Modification of NK Cell for Targeted Cancer Treatment. Pharmaceutics 2024, 16, 1189.
https://doi.org/10.3390/pharmaceutics16091189
AMA Style
Lim SY, Kim L, Kim H, Park J-A, Yun J, Lim KS.
Synergistic Chemo-Immunotherapy: Recombinant Fusion Protein-Based Surface Modification of NK Cell for Targeted Cancer Treatment. Pharmaceutics. 2024; 16(9):1189.
https://doi.org/10.3390/pharmaceutics16091189
Chicago/Turabian Style
Lim, Su Yeon, Luna Kim, Hongbin Kim, Jeong-Ann Park, Jina Yun, and Kwang Suk Lim.
2024. "Synergistic Chemo-Immunotherapy: Recombinant Fusion Protein-Based Surface Modification of NK Cell for Targeted Cancer Treatment" Pharmaceutics 16, no. 9: 1189.
https://doi.org/10.3390/pharmaceutics16091189
APA Style
Lim, S. Y., Kim, L., Kim, H., Park, J.-A., Yun, J., & Lim, K. S.
(2024). Synergistic Chemo-Immunotherapy: Recombinant Fusion Protein-Based Surface Modification of NK Cell for Targeted Cancer Treatment. Pharmaceutics, 16(9), 1189.
https://doi.org/10.3390/pharmaceutics16091189